Mode
Text Size
Log in / Sign up
N/A N=10 Randomized Single-blind Basic Science

Physiological Effects of New Polyphenol-enriched Foods in Humans

Healthy

Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Aug 2012
Primary outcome: Primary: Serum Polyphenol Concentrations Over 24h From Food Consumption — 1.7; 12.1; 7.7; 0.01 nmol*h/L — p=0.02

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
free curcumin (Other); encapsulated curcumin (Other); encapsulated curcumin + PQG (Other); free cocoa polyphenol (Other); encapsulated cocoa polyphenols (Other); control nut cream (Other)
Age
Adult · 18+ yrs
Sex
All
Sponsor
Federico II University
Primary completion
Feb 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Serum Polyphenol Concentrations Over 24h From Food Consumption
1.7; 12.1; 7.7; 0.01; 7.3; 0.5 0.02 sig
PRIMARY
Urinary Excretion of Total Polyphenols
2.0; 2.21; 9.67; 19.1; 4.92; 1.31 0.01 sig
PRIMARY
Amount of Total Fecal Polyphenols
3.49; 0.49; 27.98; 4.27; 150.97; 0.59 0.04 sig

Summary

Polyphenolic compounds exert several health benefits depending on bioavailability. Encapsulation may improve bioavailability of these compounds.This study will evaluate bioavailability of some polyphenols (curcumin and cocoa polyphenols) from new enriched-foods. In particular bread and nut based creams will be used as food matrices to include free or encapsulated polyphenols.

Eligibility Criteria

Inclusion Criteria

  • 18 - 45 years old, male and female
  • Healthy by medical assessment
  • Normal weight: BMI 18 - 25
  • Sign of a written informed consent

Exclusion Criteria

  • Age > 18 and < 45 years old
  • Pregnancy or breastfeeding
  • Intestinal or metabolic diseases/disorders such as diabetic, renal, hepatic, hypertension, pancreatic or ulcer, including lactose-intolerance
  • Previous abdominal/gastrointestinal surgery
  • Regular consumption of medication
  • Antibiotic therapy within 2 months previous the study
  • Food allergies and intolerances (celiac disease, lactose intolerance, nut allergy etc)
  • Unwilling to consume experimental foods
  • Concurrent participation or having participated to another clinical trial during the last 3 weeks
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01288859). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search